CASP1 and COVID-19: In the present study of three prospective cohorts of COVID-19-patients, we investigated caspase-1 activation and IL-1 signature using post-mortem lung tissue, bronchoalveolar lavage fluid (BALF), and serum across the spectrum of COVID-19 severity.